{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:57:24Z","timestamp":1791291444856,"version":"4.3.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,4,16]],"date-time":"2015-04-16T00:00:00Z","timestamp":1429142400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s11926-015-0505-4","type":"journal-article","created":{"date-parts":[[2015,4,15]],"date-time":"2015-04-15T09:13:43Z","timestamp":1429089223000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Functional Autoantibodies in Systemic Sclerosis Pathogenesis"],"prefix":"10.1007","volume":"17","author":[{"given":"Angela","family":"Kill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Riemekasten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,16]]},"reference":[{"key":"505_CR1","doi-asserted-by":"crossref","first-page":"R172","DOI":"10.1186\/ar3495","volume":"13","author":"R Mierau","year":"2011","unstructured":"Mierau R et al. Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical features. Arthritis Res Ther. 2011;13:R172.","journal-title":"Arthritis Res Ther"},{"key":"505_CR2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/rheumatology\/37.1.15","volume":"37","author":"CC Bunn","year":"1998","unstructured":"Bunn CC, Denton CP, Shi-Wen X, Knight C, Black CM. Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis. Br J Rheumatol. 1998;37:15\u201320.","journal-title":"Br J Rheumatol"},{"key":"505_CR3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/rheumatology\/37.1.39","volume":"37","author":"S Jacobsen","year":"1998","unstructured":"Jacobsen S et al. Clinical features and serum antinuclear antibodies in 230 Danish patients with systemic sclerosis. Br J Rheumatol. 1998;37:39\u201345.","journal-title":"Br J Rheumatol"},{"key":"505_CR4","first-page":"104","volume":"34","author":"OC Meyer","year":"2007","unstructured":"Meyer OC, Fertig N, Lucas M, Somogyi N, Medsger Jr TA. Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis. J Rheumatol. 2007;34:104\u20139.","journal-title":"J Rheumatol"},{"key":"505_CR5","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2133.2007.08392.x","volume":"158","author":"Y Hamaguchi","year":"2008","unstructured":"Hamaguchi Y et al. The clinical relevance of serum antinuclear antibodies in Japanese patients with systemic sclerosis. Br J Dermatol. 2008;158:487\u201395.","journal-title":"Br J Dermatol"},{"key":"505_CR6","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1136\/annrheumdis-2011-200631","volume":"71","author":"CP Denton","year":"2012","unstructured":"Denton CP et al. Demographic, clinical and antibody characteristics of patients with digital ulcers in systemic sclerosis: data from the DUO Registry. Ann Rheum Dis. 2012;71:718\u201321.","journal-title":"Ann Rheum Dis"},{"key":"505_CR7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semarthrit.2005.03.005","volume":"35","author":"VD Steen","year":"2005","unstructured":"Steen VD. Autoantibodies in systemic sclerosis. Semin Arthritis Rheum. 2005;35:35\u201342.","journal-title":"Semin Arthritis Rheum"},{"key":"505_CR8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1172\/JCI118377","volume":"97","author":"D Carvalho","year":"1996","unstructured":"Carvalho D, Savage CO, Black CM, Pearson JD. IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro. Induction of adhesion molecule expression and involvement of endothelium-derived cytokines. J Clin Invest. 1996;97:111\u20139.","journal-title":"J Clin Invest"},{"key":"505_CR9","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1002\/1529-0131(200011)43:11<2550::AID-ANR24>3.0.CO;2-H","volume":"43","author":"R Sgonc","year":"2000","unstructured":"Sgonc R et al. Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95. Arthritis Rheum. 2000;43:2550\u201362.","journal-title":"Arthritis Rheum"},{"key":"505_CR10","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1002\/art.21952","volume":"54","author":"SS Ahmed","year":"2006","unstructured":"Ahmed SS, Tan FK, Arnett FC, Jin L, Geng YJ. Induction of apoptosis and fibrillin 1 expression in human dermal endothelial cells by scleroderma sera containing anti-endothelial cell antibodies. Arthritis Rheum. 2006;54:2250\u201362.","journal-title":"Arthritis Rheum"},{"key":"505_CR11","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1002\/art.11179","volume":"48","author":"M Worda","year":"2003","unstructured":"Worda M et al. In vivo analysis of the apoptosis-inducing effect of anti-endothelial cell antibodies in systemic sclerosis by the chorionallantoic membrane assay. Arthritis Rheum. 2003;48:2605\u201314.","journal-title":"Arthritis Rheum"},{"key":"505_CR12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.vph.2013.05.002","volume":"59","author":"SI Wolf","year":"2013","unstructured":"Wolf SI, Howat S, Abraham DJ, Pearson JD, Lawson C. Agonistic anti-ICAM-1 antibodies in scleroderma: activation of endothelial pro-inflammatory cascades. Vasc Pharmacol. 2013;59:19\u201326.","journal-title":"Vasc Pharmacol"},{"key":"505_CR13","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1002\/art.10361","volume":"46","author":"C Chizzolini","year":"2002","unstructured":"Chizzolini C et al. Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis. Arthritis Rheum. 2002;46:1602\u201313.","journal-title":"Arthritis Rheum"},{"key":"505_CR14","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa052955","volume":"354","author":"SS Baroni","year":"2006","unstructured":"Baroni SS et al. Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N Engl J Med. 2006;354:2667\u201376.","journal-title":"N Engl J Med"},{"key":"505_CR15","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/1523-1747.ep12394936","volume":"103","author":"K Takeda","year":"1994","unstructured":"Takeda K, Hatamochi A, Ueki H, Nakata M, Oishi Y. Decreased collagenase expression in cultured systemic sclerosis fibroblasts. J Investig Dermatol. 1994;103:359\u201363.","journal-title":"J Investig Dermatol"},{"key":"505_CR16","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1046\/j.1523-1747.2003.12097.x","volume":"120","author":"S Sato","year":"2003","unstructured":"Sato S, Hayakawa I, Hasegawa M, Fujimoto M, Takehara K. Function blocking autoantibodies against matrix metalloproteinase-1 in patients with systemic sclerosis. J Investig Dermatol. 2003;120:542\u20137.","journal-title":"J Investig Dermatol"},{"key":"505_CR17","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1365-2249.2004.02615.x","volume":"138","author":"C Nishijima","year":"2004","unstructured":"Nishijima C et al. Autoantibody against matrix metalloproteinase-3 in patients with systemic sclerosis. Clin Exp Immunol. 2004;138:357\u201363.","journal-title":"Clin Exp Immunol"},{"key":"505_CR18","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/ard.2010.135772","volume":"70","author":"G Riemekasten","year":"2011","unstructured":"Riemekasten G et al. Involvement of functional autoantibodies against vascular receptors in systemic sclerosis. Ann Rheum Dis. 2011;70:530\u20136.","journal-title":"Ann Rheum Dis"},{"key":"505_CR19","doi-asserted-by":"crossref","unstructured":"Becker MO, Kill A, Kutsche M, Guenther J, Rose A, Tabeling C, Witzenrath M, K\u00fchl AA, Heidecke H, Ghofrani HA, Tiede H, Schermuly RT, Nickel N, Hoeper MM, Lukitsch I, Gollasch M, Kuebler WM, Bock S, Burmester GR, Dragun D, Riemekasten G. Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis. Am J Respir Crit Care Med. 2014;190(7):808\u201317.","DOI":"10.1164\/rccm.201403-0442OC"},{"key":"505_CR20","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1046\/j.1523-1747.1999.00476.x","volume":"112","author":"P Sambo","year":"1999","unstructured":"Sambo P et al. Monocytes of patients with systemic sclerosis (scleroderma spontaneously release in vitro increased amounts of superoxide anion. J Investig Dermatol. 1999;112:78\u201384.","journal-title":"J Investig Dermatol"},{"key":"505_CR21","first-page":"753","volume":"9","author":"KJ Lindqvist","year":"1971","unstructured":"Lindqvist KJ, Osterland CK. Human antibodies to vascular endothelium. Clin Exp Immunol. 1971;9:753\u201360.","journal-title":"Clin Exp Immunol"},{"key":"505_CR22","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1136\/ard.56.4.230","volume":"56","author":"M Hebbar","year":"1997","unstructured":"Hebbar M et al. Assessment of anti-endothelial cell antibodies in systemic sclerosis and Sjogren\u2019s syndrome. Ann Rheum Dis. 1997;56:230\u20134.","journal-title":"Ann Rheum Dis"},{"key":"505_CR23","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/CDLI.6.2.156-160.1999","volume":"6","author":"Y Renaudineau","year":"1999","unstructured":"Renaudineau Y et al. Anti-endothelial cell antibodies in systemic sclerosis. Clin Diagn Lab Immunol. 1999;6:156\u201360.","journal-title":"Clin Diagn Lab Immunol"},{"key":"505_CR24","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1365-2249.2000.01115.x","volume":"119","author":"H Ihn","year":"2000","unstructured":"Ihn H et al. Characterization of autoantibodies to endothelial cells in systemic sclerosis (SSc): association with pulmonary fibrosis. Clin Exp Immunol. 2000;119:203\u20139.","journal-title":"Clin Exp Immunol"},{"key":"505_CR25","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0002-9343(96)00404-4","volume":"102","author":"KV Salojin","year":"1997","unstructured":"Salojin KV et al. Antiendothelial cell antibodies: useful markers of systemic sclerosis. Am J Med. 1997;102:178\u201385.","journal-title":"Am J Med"},{"key":"505_CR26","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1309\/8HVCMJMYNPUQPBD2","volume":"120","author":"R Wusirika","year":"2003","unstructured":"Wusirika R et al. The assessment of anti-endothelial cell antibodies in scleroderma-associated pulmonary fibrosis. A study of indirect immunofluorescent and western blot analysis in 49 patients with scleroderma. Am J Clin Pathol. 2003;120:596\u2013606.","journal-title":"Am J Clin Pathol"},{"key":"505_CR27","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S1568-9972(02)00063-0","volume":"1","author":"Y Renaudineau","year":"2002","unstructured":"Renaudineau Y, Dugue C, Dueymes M, Youinou P. Antiendothelial cell antibodies in systemic lupus erythematosus. Autoimmun Rev. 2002;1:365\u201372.","journal-title":"Autoimmun Rev"},{"key":"505_CR28","first-page":"551","volume":"26","author":"AM Salih","year":"1999","unstructured":"Salih AM, Nixon NB, Dawes PT, Mattey DL. Soluble adhesion molecules and anti-endothelial cell antibodies in patients with rheumatoid arthritis complicated by peripheral neuropathy. J Rheumatol. 1999;26:551\u20135.","journal-title":"J Rheumatol"},{"key":"505_CR29","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1136\/ard.2005.035295","volume":"65","author":"C Belizna","year":"2006","unstructured":"Belizna C, Duijvestijn A, Hamidou M, Tervaert JW. Antiendothelial cell antibodies in vasculitis and connective tissue disease. Ann Rheum Dis. 2006;65:1545\u201350.","journal-title":"Ann Rheum Dis"},{"key":"505_CR30","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/thx.2004.029082","volume":"60","author":"MC Tamby","year":"2005","unstructured":"Tamby MC et al. Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension. Thorax. 2005;60:765\u201372.","journal-title":"Thorax"},{"key":"505_CR31","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.clim.2006.02.006","volume":"120","author":"A Servettaz","year":"2006","unstructured":"Servettaz A et al. Anti-endothelial cell antibodies from patients with limited cutaneous systemic sclerosis bind to centromeric protein B (CENP-B). Clin Immunol. 2006;120:212\u20139.","journal-title":"Clin Immunol"},{"key":"505_CR32","first-page":"527","volume":"16","author":"A Pignone","year":"1998","unstructured":"Pignone A et al. Anti-endothelial cell antibodies in systemic sclerosis: significant association with vascular involvement and alveolo-capillary impairment. Clin Exp Rheumatol. 1998;16:527\u201332.","journal-title":"Clin Exp Rheumatol"},{"key":"505_CR33","first-page":"462","volume":"25","author":"VS Negi","year":"1998","unstructured":"Negi VS, Tripathy NK, Misra R, Nityanand S. Antiendothelial cell antibodies in scleroderma correlate with severe digital ischemia and pulmonary arterial hypertension. J Rheumatol. 1998;25:462\u20136.","journal-title":"J Rheumatol"},{"key":"505_CR34","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1172\/JCI118851","volume":"98","author":"R Sgonc","year":"1996","unstructured":"Sgonc R et al. Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma. J Clin Invest. 1996;98:785\u201392.","journal-title":"J Clin Invest"},{"key":"505_CR35","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1183\/09031936.06.00152705","volume":"28","author":"MC Tamby","year":"2006","unstructured":"Tamby MC et al. Antibodies to fibroblasts in idiopathic and scleroderma-associated pulmonary hypertension. Eur Respir J. 2006;28:799\u2013807.","journal-title":"Eur Respir J"},{"key":"505_CR36","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/ard.2008.104299","volume":"69","author":"B Terrier","year":"2010","unstructured":"Terrier B et al. Antifibroblast antibodies from systemic sclerosis patients bind to {alpha}-enolase and are associated with interstitial lung disease. Ann Rheum Dis. 2010;69:428\u201333.","journal-title":"Ann Rheum Dis"},{"key":"505_CR37","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1136\/ard.2007.085480","volume":"67","author":"E Balada","year":"2008","unstructured":"Balada E et al. Anti-PDGFR-alpha antibodies measured by non-bioactivity assays are not specific for systemic sclerosis. Ann Rheum Dis. 2008;67:1027\u20139.","journal-title":"Ann Rheum Dis"},{"key":"505_CR38","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/art.24365","volume":"60","author":"N Loizos","year":"2009","unstructured":"Loizos N et al. Lack of detection of agonist activity by antibodies to platelet-derived growth factor receptor alpha in a subset of normal and systemic sclerosis patient sera. Arthritis Rheum. 2009;60:1145\u201351.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"505_CR39","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/art.24364","volume":"60","author":"D Dragun","year":"2009","unstructured":"Dragun D, Distler JH, Riemekasten G, Distler O. Stimulatory autoantibodies to platelet-derived growth factor receptors in systemic sclerosis: what functional autoimmunity could learn from receptor biology. Arthritis Rheum. 2009;60(4):907\u201311.","journal-title":"Arthritis Rheum"},{"key":"505_CR40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1346-8138.2009.00738.x","volume":"37","author":"M Jinnin","year":"2010","unstructured":"Jinnin M. Mechanisms of skin fibrosis in systemic sclerosis. J Dermatol. 2010;37:11\u201325.","journal-title":"J Dermatol"},{"key":"505_CR41","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-2133.1979.tb01635.x","volume":"100","author":"CR Lovell","year":"1979","unstructured":"Lovell CR, Nicholls AC, Duance VC, Bailey AJ. Characterization of dermal collagen in systemic sclerosis. Br J Dermatol. 1979;100:359\u201369.","journal-title":"Br J Dermatol"},{"key":"505_CR42","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0889-857X(05)70294-5","volume":"22","author":"SA Jimenez","year":"1996","unstructured":"Jimenez SA, Hitraya E, Varga J. Pathogenesis of scleroderma. Collagen. Rheum Dis Clin N Am. 1996;22:647\u201374.","journal-title":"Rheum Dis Clin N Am"},{"key":"505_CR43","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/ar4457","volume":"16","author":"A Kill","year":"2014","unstructured":"Kill A et al. Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis. Arthritis Res Ther. 2014;16:R29.","journal-title":"Arthritis Res Ther"},{"key":"505_CR44","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1186\/ar4503","volume":"16","author":"J Gunther","year":"2014","unstructured":"Gunther J et al. Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients. Arthritis Res Ther. 2014;16:R65.","journal-title":"Arthritis Res Ther"},{"key":"505_CR45","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1749-6632.2009.05383.x","volume":"1193","author":"M Cutolo","year":"2010","unstructured":"Cutolo M et al. The immunomodulatory effects of estrogens: clinical relevance in immune-mediated rheumatic diseases. Ann N Y Acad Sci. 2010;1193:36\u201342.","journal-title":"Ann N Y Acad Sci"},{"key":"505_CR46","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.imlet.2010.06.003","volume":"132","author":"M Pierdominici","year":"2010","unstructured":"Pierdominici M et al. Estrogen receptor profiles in human peripheral blood lymphocytes. Immunol Lett. 2010;132:79\u201385.","journal-title":"Immunol Lett"},{"key":"505_CR47","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/art.33400","volume":"64","author":"T Colasanti","year":"2012","unstructured":"Colasanti T et al. Autoantibodies to estrogen receptor alpha interfere with T lymphocyte homeostasis and are associated with disease activity in systemic lupus erythematosus. Arthritis Rheum. 2012;64:778\u201387.","journal-title":"Arthritis Rheum"},{"key":"505_CR48","doi-asserted-by":"crossref","first-page":"e74332","DOI":"10.1371\/journal.pone.0074332","volume":"8","author":"A Giovannetti","year":"2013","unstructured":"Giovannetti A et al. Autoantibodies to estrogen receptor alpha in systemic sclerosis (SSc) as pathogenetic determinants and markers of progression. PLoS One. 2013;8:e74332.","journal-title":"PLoS One"},{"key":"505_CR49","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1002\/1529-0131(200111)44:11<2653::AID-ART445>3.0.CO;2-1","volume":"44","author":"P Sambo","year":"2001","unstructured":"Sambo P et al. Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway. Arthritis Rheum. 2001;44:2653\u201364.","journal-title":"Arthritis Rheum"},{"key":"505_CR50","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00403-009-0996-9","volume":"302","author":"F Ogawa","year":"2010","unstructured":"Ogawa F et al. Autoantibody against one of the antioxidant repair enzymes, methionine sulfoxide reductase A, in systemic sclerosis: association with pulmonary fibrosis and vascular damage. Arch Dermatol Res. 2010;302:27\u201335.","journal-title":"Arch Dermatol Res"},{"key":"505_CR51","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s10620-007-0018-8","volume":"53","author":"R Domsic","year":"2008","unstructured":"Domsic R, Fasanella K, Bielefeldt K. Gastrointestinal manifestations of systemic sclerosis. Dig Dis Sci. 2008;53:1163\u201374.","journal-title":"Dig Dis Sci"},{"key":"505_CR52","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0889-8553(05)70021-2","volume":"27","author":"S Rose","year":"1998","unstructured":"Rose S, Young MA, Reynolds JC. Gastrointestinal manifestations of scleroderma. Gastroenterol Clin N Am. 1998;27:563\u201394.","journal-title":"Gastroenterol Clin N Am"},{"key":"505_CR53","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/ard.2008.096545","volume":"68","author":"Y Kawaguchi","year":"2009","unstructured":"Kawaguchi Y et al. Muscarinic-3 acetylcholine receptor autoantibody in patients with systemic sclerosis: contribution to severe gastrointestinal tract dysmotility. Ann Rheum Dis. 2009;68:710\u20134.","journal-title":"Ann Rheum Dis"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-015-0505-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-015-0505-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-015-0505-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T22:24:17Z","timestamp":1598912657000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-015-0505-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,16]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["505"],"URL":"https:\/\/doi.org\/10.1007\/s11926-015-0505-4","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,16]]},"article-number":"34"}}